Results RNA, LLC is recalling 10,297 bottles of Lubrisine eye drops (polyethylene glycol 400 0.4% and propylene glycol 0.3%) because the product lacks sterility assurance and contains undeclared colloidal silver. The recall affects all lots of the 30 ML bottles distributed nationwide. Because these are eye drops, a lack of sterility poses a serious risk of infection, and the presence of undeclared ingredients like colloidal silver can cause further adverse reactions. Consumers should contact their healthcare provider or pharmacist regarding the use of this product.
A lack of sterility in eye drops can introduce bacteria directly into the eye, potentially leading to severe infections or permanent vision loss. Additionally, the undeclared presence of colloidal silver may cause unintended side effects or allergic reactions in sensitive individuals.
Refund and Healthcare Consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.